je.st
news
Tag: cancer vaccines
Merck and Moderna Announce Strategic Collaboration to Advance Novel mRNA-Based Personalized Cancer Vaccines with KEYTRUDA (pembrolizumab) for the Treatment of Multiple Types of Cancer
2016-06-29 13:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. & CAMBRIDGE, Mass. Collaboration Combines Mercks Leadership in Immuno-Oncology with Modernas Pioneering mRNA Vaccine Technology and Rapid Cycle Time, Small-Batch GMP Manufacturing Capabilities KENILWORTH, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Moderna Therapeutics today announced a strategic collaboration and license agreement to develop and commercialize novel messenger RNA (mRNA)-based personalized cancer vaccines. Language: English Contact: Merck Media:Pamela Eisele, 267-305-3558orCourtney Ronaldo, 908-236-1108orInvestors:Teri Loxam, 908-740-1986orJustin Holko, 908-740-1879or Moderna Media:Liz Melone, 617-256-6622orInvestors:Maren Winnick, 617-674-5297 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: of
types
multiple
treatment
Injectable cryogel-based whole-cell cancer vaccines
2015-08-26 12:18:31| Biotech - Topix.net
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors offers a promising strategy against patient-specific cancer cells Cancerous melanoma cells shown with their cell bodies and nuclei are nestled in tiny hollow lumens within the polymeric cryogel structure. Credit: Wyss Institute at Harvard University New research led by Wyss Core Faculty member David Mooney, Ph.D., in collaboration with researchers at the Dana-Farber Cancer Institute could potentially yield a new platform for cancer vaccines.
Tags: cancer
vaccines
injectable
cancer vaccines
Sites : [1]